Michael Leuchten
Stock Analyst at Jefferies
(2.52)
# 2,267
Out of 5,112 analysts
13
Total ratings
80%
Success rate
9.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Leuchten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVO Novo Nordisk | Assumes: Underperform | n/a | $47.77 | - | 5 | Oct 27, 2025 | |
| NVS Novartis AG | Assumes: Hold | n/a | $135.03 | - | 1 | Oct 27, 2025 | |
| GSK GSK plc | Assumes: Buy | n/a | $48.71 | - | 1 | Oct 27, 2025 | |
| AZN AstraZeneca | Assumes: Buy | n/a | $89.86 | - | 5 | Oct 27, 2025 | |
| SNY Sanofi | Downgrades: Underweight | n/a | $48.14 | - | 1 | Jan 23, 2018 |
Novo Nordisk
Oct 27, 2025
Assumes: Underperform
Price Target: n/a
Current: $47.77
Upside: -
Novartis AG
Oct 27, 2025
Assumes: Hold
Price Target: n/a
Current: $135.03
Upside: -
GSK plc
Oct 27, 2025
Assumes: Buy
Price Target: n/a
Current: $48.71
Upside: -
AstraZeneca
Oct 27, 2025
Assumes: Buy
Price Target: n/a
Current: $89.86
Upside: -
Sanofi
Jan 23, 2018
Downgrades: Underweight
Price Target: n/a
Current: $48.14
Upside: -